Dietary Antioxidant Intake and Risk of Type 2 Diabetes
Response to Montonen et al.
- Fernando Granado-Lorencio, PHD1 and
- Begona Olmedilla-Alonso, PHARMD, PHD2
- 1Unidad de Vitaminas, Hospital Universitario Puerta de Hierro, Madrid, Spain
- 2Redes Temáticas de Investigación del Instituto de Salud Carlos III, Madrid, Spain. RCMN C03/08 and RGMBE G03/090 (B.O.-A)
- Address correspondence to Fernando Granado-Lorencio, PhD, Hospital Universitario Puerta de Hierro, Unidad de Vitaminas, 28035 Madrid, Spain. E-mail: bolmedilla.hpth{at}salud.madrid.org
The results by Montonen et al. (1) regarding the potential role of dietary antioxidants in the prevention of type 2 diabetes are of considerable interest. The authors identify β-cryptoxanthin as a preventive factor, regardless of adjustment for other potential confounding factors, and point out that data support the hypothesis that “a sufficient intake of antioxidants plays a role in type 2 diabetes prevention.”
Although the follow-up time and number of subjects are considerable, …
